Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imatinib for advanced liver fibrosis
IRCT20200809048342N1Phase 2Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial in hepatic fibrosis comparing Imatinib plus standard medication with Placebo plus standard medication (2 arms). Primary endpoints: Liver fibrosis score by FibroScan, Alanine aminotransferase and 11 more. Started Sep 2020; status: completed.
02
Drugs
03
Conditions
hepatic fibrosis
Beyond the preview
Go deeper on IRCT20200809048342N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200809048342N1.